Arcus Biosciences Inc (RCUS)

Return on assets (ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	-283,000	-270,000	-249,000	-231,000	-307,000	-293,000	-287,000	-279,000	-267,000	79,538	66,563	57,593	53,000	-278,391	-198,594	-167,698	-122,858	-87,603	-111,777	-94,793
Total assets	US$ in thousands	1,150,000	1,252,000	1,186,000	1,293,000	1,095,000	1,191,000	1,220,000	1,254,000	1,345,000	1,393,820	1,476,770	1,543,430	1,592,000	839,290	898,773	935,119	772,292	811,075	481,389	176,144
ROA		-24.61%	-21.57%	-20.99%	-17.87%	-28.04%	-24.60%	-23.52%	-22.25%	-19.85%	5.71%	4.51%	3.73%	3.33%	-33.17%	-22.10%	-17.93%	-15.91%	-10.80%	-23.22%	-53.82%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $-283,000K ÷ $1,150,000K
= -24.61%

Arcus Biosciences Inc's return on assets (ROA) fluctuated significantly over the analyzed period. From March 31, 2020, to June 30, 2022, the ROA remained negative, indicating that the company was not generating satisfactory returns on its assets during this time frame.

However, starting from December 31, 2021, the ROA turned positive, reaching its peak at 5.71% on September 30, 2022. This positive trend was a positive sign that the company was becoming more efficient in generating profits from its assets.

Unfortunately, the positive trend did not continue, and the ROA started declining again from December 31, 2022, reaching -24.61% by December 31, 2024. This decline suggests that the company may be facing challenges in effectively utilizing its assets to generate profits.

In conclusion, Arcus Biosciences Inc's ROA showed a mix of negative and positive trends over the analyzed period, highlighting the company's variable performance in terms of asset efficiency and profitability.